Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “Theravance, Inc.”

369 pharma patents match "Theravance, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 369
Index total 30,257
Page 11 / 16

Quick answer

This filtered view shows 369 pharmaceutical patents matching "Theravance, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

369 results for “Theravance, Inc.” · 30,257 patents in full index Clear search

  1. US 7521561

    Biphenyl derivatives

    Theravance, Inc. · Granted Apr 21, 2009 · Expires Apr 16, 2029

    granted

  2. US 7521418

    Use of a polyene macrolide antifungal agent in combination with a glycopeptide antibacterial agent

    Theravance, Inc. · Granted Apr 21, 2009 · Expires Apr 16, 2029

    granted

  3. US 7521041

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Apr 21, 2009 · Expires Apr 16, 2029

    granted

  4. US 7521558

    Crystalline form of a biphenyl compound

    Theravance, Inc. · Granted Apr 21, 2009 · Expires Apr 16, 2029

    granted

  5. US 7514425

    Short-acting sedative hypnotic agents for anesthesia and sedation

    Theravance, Inc. · Granted Apr 7, 2009 · Expires Apr 2, 2029

    granted

  6. US 7514558

    Biphenyl derivatives

    Theravance, Inc. · Granted Apr 7, 2009 · Expires Apr 2, 2029

    granted

  7. US 7507751

    Biphenyl derivatives

    Theravance, Inc. · Granted Mar 24, 2009 · Expires Mar 19, 2029

    granted

  8. US 7501442

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Mar 10, 2009 · Expires Mar 5, 2029

    granted

  9. US 7498442

    Quinolinone-carboxamide compounds

    Theravance, Inc. · Granted Mar 3, 2009 · Expires Feb 26, 2029

    granted

  10. US 7491736

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Feb 17, 2009 · Expires Feb 12, 2029

    granted

  11. US 7479562

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Jan 20, 2009 · Expires Jan 15, 2029

    granted

  12. US 7468420

    Process for purifying glycopeptide phosphonate derivatives

    Theravance, Inc. · Granted Dec 23, 2008 · Expires Dec 18, 2028

    granted

  13. US 7456203

    Muscarinic receptor antagonists

    Theravance, Inc. · Granted Nov 25, 2008 · Expires Nov 20, 2028

    granted

  14. US 7456199

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Nov 25, 2008 · Expires Nov 20, 2028

    granted

  15. US 7452861

    Use of an echinocandin antifungal agent in combination with a glycopeptide antibacterial agent

    Theravance, Inc. · Granted Nov 18, 2008 · Expires Nov 13, 2028

    granted

  16. US 7452995

    Aryl aniline β2 adrenergic receptor agonists

    Theravance, Inc. · Granted Nov 18, 2008 · Expires Nov 13, 2028

    granted

  17. US 7446114

    Quinolinone compounds as 5-HT4 receptor agonists

    Theravance, Inc. · Granted Nov 4, 2008 · Expires Oct 30, 2028

    granted

  18. US 7427639

    β2-adrenergic receptor agonists

    Theravance, Inc. · Granted Sep 23, 2008 · Expires Sep 18, 2028

    granted

  19. US 7419989

    Indazole-carboxamide compounds

    Theravance, Inc. · Granted Sep 2, 2008 · Expires Aug 28, 2028

    granted

  20. US 7405199

    Cross-linked glycopeptide-cephalosporin antibiotics

    Theravance, Inc. · Granted Jul 29, 2008 · Expires Jul 24, 2028

    granted

  21. US 7402673

    Diamine β2 adrenergic receptor agonists

    Theravance, Inc. · Granted Jul 22, 2008 · Expires Jul 17, 2028

    granted

  22. US 7399862

    5-HT4 receptor agonist compounds

    Theravance, Inc. · Granted Jul 15, 2008 · Expires Jul 10, 2028

    granted

  23. US 7399863

    Amino-substituted ethylamino β2 adrenergic receptor agonists

    Theravance, Inc. · Granted Jul 15, 2008 · Expires Jul 10, 2028

    granted

  24. US 7396933

    Quinolinone-carboxamide compounds

    Theravance, Inc. · Granted Jul 8, 2008 · Expires Jul 3, 2028

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.